Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter V Henstock

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|June 18, 2019
Artificial Intelligence for Pharma: Time for Internal InvestmentPeter V Henstock
Plos One|July 27, 2016
CATO: The Clone Alignment ToolPeter V Henstock, Peter LaPan
International Immunopharmacology|April 20, 2010
ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha releaseFei Hua, Peter V Henstock, Betty Tang
Journal of Cancer|October 8, 2011
miRNA Alterations Modify Kinase Activation In The IGF-1 Pathway And Correlate With Colorectal Cancer Stage And Progression In PatientsDavid L Knowlton, Kim Tang, Peter V Henstock, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 6, 2008
Cellular imaging predictions of clinical drug-induced liver injuryJinghai J Xu, Peter V Henstock, Margaret C Dunn, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2024
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapiesAmit Chhabra, George Bashirians, Christos J Petropoulos, et al.
JAMIA Open|May 31, 2024
Using large language models for safety-related table summarization in clinical study reportsRogier Landman, Sean P Healey, Vittorio Loprinzo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|June 18, 2019
Artificial Intelligence for Pharma: Time for Internal InvestmentPeter V Henstock
Plos One|July 27, 2016
CATO: The Clone Alignment ToolPeter V Henstock, Peter LaPan
International Immunopharmacology|April 20, 2010
ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha releaseFei Hua, Peter V Henstock, Betty Tang
Journal of Cancer|October 8, 2011
miRNA Alterations Modify Kinase Activation In The IGF-1 Pathway And Correlate With Colorectal Cancer Stage And Progression In PatientsDavid L Knowlton, Kim Tang, Peter V Henstock, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 6, 2008
Cellular imaging predictions of clinical drug-induced liver injuryJinghai J Xu, Peter V Henstock, Margaret C Dunn, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2024
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapiesAmit Chhabra, George Bashirians, Christos J Petropoulos, et al.
JAMIA Open|May 31, 2024
Using large language models for safety-related table summarization in clinical study reportsRogier Landman, Sean P Healey, Vittorio Loprinzo, et al.
Pageof 1